Is there a role for supplemented antioxidants in the prevention of atherosclerosis?

Clinical Nutrition

Volumn 28, Issue 1, 2009, Pages 3-9

  Katsiki, Niki ^a   Manes, Christos ^a  

^a Hospital Papageorgiou   (Greece)

Author keywords

Antioxidants; Clinical trials; Prevention of atherosclerosis; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; COLESTIPOL; FOLIC ACID; MULTIVITAMIN; NICOTINIC ACID; PLACEBO; PROBUCOL; RETINOL; SELENIUM; SIMVASTATIN; ZINC;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; LOW FAT DIET; MEDLINE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANTIOXIDANTS; ATHEROSCLEROSIS; DIETARY SUPPLEMENTS; HUMANS; OXIDATIVE STRESS; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMINS;

EID: 59149089613     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2008.10.011     Document Type: Review

References (67)

1. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 84 (2004) 1381-1478
2. De Nigris F., Lerman A., Ignarro L.J., Williams-Ignarro S., Sica V., Baker A.H., et al. Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol Med 9 (2003) 351-359
3. Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient. A call for new definitions and risk assessment strategies: part II. Circulation 108 (2003) 1772-1778
4. Cherubini A., Vigna G.B., Zuliani G., Ruggiero C., Senin U., and Fellin R. Role of antioxidants in atherosclerosis: epidemiological and clinical update. Curr Pharm Des 11 (2005) 2017-2032
5. Tardif J.C., Gregoire J., Lavoie M.A., and L' Allier P.L. Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies. Curr Opin Lipidol 14 (2003) 615-620
6. Salonen J., Nyyssonen K., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Rissanen T.H., et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the antioxidant supplementation in atherosclerosis prevention (ASAP) study. Circulation 107 (2003) 947-953
7. Accinni R., Rosina M., Bamonti F., Della Noce C., Tonini A., Bernacchi F., et al. Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutr Metab Cardiovasc Dis 16 (2006) 121-127
8. Tagawa T., Urabe Y., Kimura Y., Suzuki S., Ono H., and Takeda K. Long-term treatment with probucol improves endothelial function in patients with coronary artery disease. Hypertens Res 27 (2004) 311-318
9. Jadad A.R., Moore R.A., and Carrol D. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
10. Jialal I., and Devaraj S. Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 107 (2003) 926-928
11. Kritharides L., and Stocker R. The use of antioxidant supplements in coronary heart disease. Atherosclerosis 164 (2002) 211-219
12. Rimm E.B., Willett W.C., Hu F.B., Sampson L., Colditz G.A., Manson J.E., et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279 (1998) 359-364
13. Jha P., Flather M., Lonn E., Farkouh M., and Yusuf S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 123 (1995) 860-872
14. Gaziano J.M., Manson J.E., Branch L.G., Colditz G.A., Willett W.C., and Buring J.E. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 5 (1995) 255-260
15. Losonczy K.G., Harris T.B., and Havlik R.J. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the established populations for epidemiologic studies of the Elderly. Am J Clin Nutr 64 (1996) 190-196
16. Tribble D.L., and AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E and beta-carotene: a statement for healthcare professionals from the American heart association. Circulation 99 (1999) 591-595
17. Brigelius-Flohe R., Kluth D., and Banning A. Is there a future for antioxidants in atherogenesis?. Mol Nutr Food Res 49 (2005) 1083-1089
18. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell Infarto miocardico. Lancet 354 (1999) 447-455
19. Yusuf S., Dagenais G., Pogue J., Bosch J., and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 154-160
20. De Gaetano G., and Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 357 (2001) 89-95
21. Lonn E., Yusuf S., Hoogwerf B., Pogue J., Yi Q., Zinman B., et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 25 (2002) 1919-1927
22. Hodis H.N., Mack W.J., LaBree L., Mahrer P.R., Sevanian A., Liu C.R., et al. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E atherosclerosis prevention study (VEAPS). Circulation 106 (2002) 1453-1459
23. Rapola J.M., Virtamo J., Ripatti S., Huttunen J.K., Albanes D., Taylor P.R., et al. Randomized trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 349 (1997) 1715-1720
24. Virtamo J., Rapola J.M., Ripatti S., Heinonen O.P., Taylor P.R., Albanes D., et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 158 (1998) 668-675
25. Greenberg E.R., Baron J.A., Karagas M.R., Stukel T.A., Nierenberg D.W., Stevens M.M., et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 275 (1996) 699-703
26. Hennekens C.H., Buring J.E., Manson J.E., Stampfer M., Rosner B., Cook N.R., et al. Lack of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334 (1996) 1145-1149
27. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360 (2002) 23-33
28. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334 (1996) 1150-1155
29. Tardif J.C., Cöté G., Lespérance J., Bourassa M., Lambert J., Doucet S., et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: multivitamins and probucol study group. N Engl J Med 337 (1997) 365-372
30. Zureik M., Galan P., Bertrais S., Mennen L., Czernichow S., Blacher J., et al. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler Thromb Vasc Biol 24 (2004) 1485-1491
31. Cook N.R., Albert C.M., Gaziano J.M., Zaharris E., MacFadyen J., Danielson E., et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women. Arch Intern Med 167 (2007) 1610-1618
32. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., and Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361 (2003) 2017-2023
33. Shekelle P.G., Morton S.C., Jungvig L.K., Udani J., Spar M., Tu W., et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med 19 (2004) 380-389
34. Eidelman R.S., Hollar D., Hebert P.R., Lamas G.A., and Hennekens C.H. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 164 (2004) 1552-1556
35. Bleys J., Miller III E.R., Pastor-Barriuso R., Appel L.J., and Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr 84 (2006) 880-887
36. Brown B.G., Zhao X.Q., Chait A., Fisher L.D., Cheung M.C., Morse J.S., et al. Simvastatin and niacin, antioxidant vitamins or the combination for the prevention of coronary disease. N Engl J Med 345 (2001) 1583-1592
37. Waters D.D., Alderman E.L., Hsia J., Howard B.V., Cobb F.R., Rogers W.J., et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 288 (2002) 2432-2440
38. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., and Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297 (2007) 842-857
39. Miller III E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., and Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142 (2005) 37-46
40. Abudu N., Miller J.J., Attaelmannan M., and Levinson S.S. Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. Clin Chim Acta 339 (2004) 11-25
41. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., and Mitchinson M.J. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 347 (1996) 781-786
42. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomized placebo-controlled trial. Lancet 356 (2000) 1213-1218
43. Singh R.B., Niaz M.A., Rastogi S.S., and Rastogi S. Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3). Am J Cardiol 77 (1996) 232-236
44. Yokoi H., Daida H., Kuwabara Y., Nishikawa H., Takatsu F., Tomihara H., et al. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the probucol angioplasty restenosis trial. J Am Coll Cardiol 30 (1997) 855-862
45. Tomoda H., Yoshitake M., Morimoto K., and Aoki N. Possible prevention of postangioplasty restenosis by ascorbic acid. Am J Cardiol 78 (1996) 1284-1286
46. Azen S.P., Qian D., Mack W.J., Sevanian A., Selzer R.H., Liu C.R., et al. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 94 (1996) 2369-2372
47. Salonen J.T., Nyyssonen K., Salonen R., Lakka H.M., Kaikkonen J., Porkkala-Sarataho E., et al. Antioxidant supplementation in atherosclerosis prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 248 (2000) 377-386
48. Fang J.C., Kinlay S., Beltrame J., Hikiti H., Wainstein M., Behrendt D., et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomized trial. Lancet 359 (2002) 1108-1113
49. Morris C.D., and Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. preventive services task force. Ann Intern Med 139 (2003) 56-70
50. Micheletta F., Natoli S., Misuraca M., Sbarigia E., Diczfalusy U., and IulianoL. Vitamin E supplementation in patients with carotid atherosclerosis. Reversal of altered oxidative stress status in plasma but not in plaque. Arterioscler Thromb Vasc Biol 24 (2004) 136-140
51. Engler M.M., Engler M.B., Malloy M.J., Chiu E.Y., Schloetter M.C., Paul S.M., et al. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia. Endothelial assessment of risk from lipids in youth (EARLY) trial. Circulation 108 (2003) 1059-1063
52. Steinberg D., and Witztum J. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?. Circulation 105 (2002) 2107-2111
53. Brigelius-Flohe R., Kelly F.J., Salonen J.T., Neuzil J., Zingg J.M., and Azzi A. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 76 (2002) 703-716
54. Huang H.Y., and Appel L.J. Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr 133 (2003) 3137-3140
55. Cooney R.V., Franke A.A., Harwood P.J., Hatch-Pigott V., Custer L.J., and Mordan L.J. Gamma-tocopherol detoxification of nitrogen dioxide; superiority to alpha-tocopherol. Proc Natl Acad Sci U S A 90 (1993) 1771-1775
56. Van Haaften R.I., Haenen G.R., van Bladeren P.J., Bogaards J.J., Evelo C.T., and Bast A. Inhibition of various glutathione S-transferase isoenzymes by RRR-alpha-tocopherol. Toxicol In Vitro 17 (2003) 245-251
57. Leonard S.W., Good C.K., Gugger E.T., and Traber M.G. Vitamin E bioavailability from fortified breakfast cereal is greater than that from encapsulated supplements. Am J Clin Nutr 79 (2004) 86-92
58. Richelle M., Enslen M., Hager C., Groux M., Tavazzi I., Godin J.P., et al. Both free and esterified plant sterols reduce cholesterol absorption and the bioavailability of beta-carotene and alpha-tocopherol in normocholesterolemic humans. Am J Clin Nutr 80 (2004) 171-177
59. Tucker J.M., and Townsend D.M. Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed Pharmacother 59 (2005) 380-387
60. Dutta A., and Dutta S.K. Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: a review. J Am Coll Nutr 22 (2003) 258-268
61. Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Res 49 (2005) 7-30
62. Bender M.M., Levy A.S., Schucker R.E., and Yetley E.A. Trends in prevalence and magnitude of vitamin and mineral supplement usage and correlation with health status. J Am Diet Assoc 92 (1992) 1096-1101
63. Meagher E.A., Barry O.P., Lawson J.A., Rokach J., and FitzGerald G.A. Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285 (2001) 1178-1182
64. Meagher E.A. Treatment of atherosclerosis in the new millennium: is there a role for vitamin E?. Prev Cardiol 6 (2003) 85-90
65. Ridker P.M., Brown N.J., Vaughan D.E., Harrison D.G., and Mehta J.L. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109 Suppl. IV (2004) IV6-IV19
66. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American heart association and nutrition committee. Circulation 114 (2006) 82-96
67. Gibbons R.J., Abrams J., Chatterjee K., Daley J., Deedwania P.C., Douglas J.S., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation 107 (2003) 149-158